Brief: Nymox Announces U.S. NDA For Fexapotide For BPH
Feb 5 (Reuters) - Nymox Pharmaceutical Corp NYMX.O :
* NYMOX ANNOUNCES US NDA FOR FEXAPOTIDE FOR BPH
* SAYS RECENTLY HAD A PRE-NDA MEETING WITH FDA; NDA FOR
FEXAPOTIDE FOR BPH WILL BE SUBMITTED LATER IN 2018
Source text for Eikon: ID:nGNXOOBEJa
Further company coverage: NYMX.O
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Nymox Pharmaceutical
See all newsBrief: Nymox Says Required To Resubmit Application To DKMA
Brief: Nymox Pharmaceutical Corp Says Terminated Employment Of Christopher R Riley As CFO (June 27)
Brief: Nymox Announces Appointment Of Christopher R. Riley As Chief Financial Officer
Brief: Nymox Appeals Deficiency Letter
U.S. STOCKS ON THE MOVE-Pot stocks, Nymox, Zynerba